Questions?arveonix@protonmail.com•Telegram @arveonix

Last updated:

ARVEONIX Ipamorelin 10mg research product box and vial
Growth signalling · SKU IP10

Ipamorelin 10mg

$80.00 AUD
In stock
Free shipping Australia-wideOrders over $150

Ipamorelin is a selective ghrelin receptor agonist studied in pituitary signalling and growth-hormone secretagogue research.

ProductIpamorelin 10mg
SKUIP10
CategoryGrowth signalling
Listed price$80.00 AUD
AvailabilityIn stock
Confirm current availability when making an enquiry.

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide classified as a growth-hormone secretagogue and is widely studied for activity at the ghrelin receptor, GHS-R1a. Research interest centres on how ghrelin-receptor signalling influences pituitary growth-hormone release and related endocrine pathways.

Ipamorelin is often characterised in research discussions as having a comparatively selective GHS-R1a profile. That makes it useful for studying ghrelin-receptor signalling separately from compounds that engage a broader range of endocrine targets.

Research category

Growth signalling

ARVEONIX format

Ipamorelin 10mg · SKU IP10

Primary research context

Ghrelin receptor and pituitary signalling

Catalogue status

In stock · $80.00 AUD

Ghrelin receptor and pituitary signalling.

GHS-R1a is a G-protein-coupled receptor involved in ghrelin signalling. In experimental models, activation of this receptor can influence pituitary signalling and patterns of growth-hormone release.

Researchers may examine receptor activation, pulsatile endocrine signalling and interactions with other growth-hormone regulatory pathways. Results depend heavily on the experimental model and should not be extrapolated beyond the evidence available.

Common research themes.

GHS-R1a

Study of ghrelin-receptor binding and downstream signalling.

Pituitary signalling

Research into pathways involved in growth-hormone release.

Pulse dynamics

Experimental work may examine patterns of hormone secretion over time.

Combination research

Ipamorelin is also studied alongside GHRH-pathway analogues such as CJC-1295 without DAC.

Research considerations.

Research findings should always be interpreted within the experimental system in which they were produced. Cell, receptor, tissue, animal and human studies can answer different questions, and results from one model should not automatically be treated as established outcomes in another.

ARVEONIX product pages therefore focus on molecule identity, pathway biology and published research themes rather than presenting experimental observations as guaranteed effects. The information here is not a dosing, treatment or individual-use recommendation.

Ipamorelin FAQs.

What is Ipamorelin?

Ipamorelin is a synthetic growth-hormone secretagogue peptide studied for selective activity at the ghrelin receptor GHS-R1a.

What receptor does Ipamorelin target?

It is primarily associated with GHS-R1a, also known as the growth-hormone secretagogue receptor.

Is Ipamorelin a GHRH analogue?

No. Ipamorelin acts through the ghrelin receptor pathway rather than the GHRH receptor.

Why is Ipamorelin paired with CJC-1295 without DAC in research?

The two compounds act through different signalling pathways, allowing researchers to study complementary regulation of pituitary growth-hormone signalling.

What strength is ARVEONIX Ipamorelin?

This catalogue product is listed as Ipamorelin 10mg under SKU IP10.

What research areas involve Ipamorelin?

Research themes include ghrelin-receptor signalling, pituitary biology and growth-hormone secretagogue pharmacology.

Does this page provide a dosing protocol?

No. It provides research context and product information only.